Esketamine
http://dbpedia.org/resource/Esketamine an entity of type: Thing
إيسكيتامين (بالإنجليزية: Esketamine) دواء يستخدم كمخدر عام، ولمعالجة الاكتئاب المقاوم للعلاج، يستخدم الإيسكيتامين عن طريق الأنف أو عن طريق الوريد.
rdf:langString
Esketamin, som säljs under bland annat varumärkena Ketanest och Spravato, är ett läkemedel som används som allmänt anestesimedel och för depression. Esketamin används som nässpray eller intravenöst.
rdf:langString
Эскетамин — лекарственный препарат для наркоза и терапии депрессии. Одобрен для применения: США (2019).
rdf:langString
Esketamine, also known as (S)-ketamine or S(+)-ketamine, is the S(+) enantiomer of ketamine, is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression. It is sold under the brand names Spravato (for depression), Ketanest (for anesthesia), among others. Esketamine is the active enantiomer of ketamine in terms of NMDA receptor antagonism and is more potent than racemic ketamine.
rdf:langString
L'eskétamine, commercialisée en France sous les marques Eskesia et Spravato entre autres, est un médicament utilisé comme anesthésique général et pour la dépression réfractaire au traitement. L'eskétamine est utilisée en spray nasal ou par injection intraveineuse. L'eskétamine a été introduite pour un usage médical en 1997. En 2019, elle a été approuvée pour être utilisée avec d'autres antidépresseurs pour le traitement de la dépression chez les adultes aux États-Unis. Le coût du spray nasal à partir de 2019 sera de 4 700 USD à 6 800 USD pour le premier mois.
rdf:langString
Escetamina(pt-BR) ou esketamina(pt-PT?), vendida sob as marcas Ketanest, Spravato, entre outros, é um medicamento usado como anestésico geral e no tratamento de depressão resistente. Escetamina é usada via spray nasal ou por meio de injeção intravenosa. Escetamina foi introduzida para uso médico em 1997. Em 2019, foi aprovada para uso conjunto com outros antidepressivos, no tratamento da depressão em adultos nos Estados Unidos. O custo médio do spray nasal em 2019 variou de US$ 4.700 a US$ 6.800, algo em torno de R$ 14.800 a R$ 21.200 em valores de 2020.
rdf:langString
rdf:langString
إيسكيتامين
rdf:langString
Esketamine
rdf:langString
Eskétamine
rdf:langString
Escetamina
rdf:langString
Esketamin
rdf:langString
Эскетамин
xsd:integer
12790813
xsd:integer
1122350702
rdf:langString
AX14
rdf:langString
N01
xsd:integer
13
xsd:integer
33643
xsd:integer
60799
60800
xsd:integer
395091
2364609
xsd:integer
158414
26332012
xsd:integer
1
rdf:langString
NMDA receptor antagonists; Antidepressants; General anesthetics; Dissociative hallucinogens; Analgesics
rdf:langString
DB01221
rdf:langString
DBSALT002086
xsd:integer
16
rdf:langString
S-ketamine-from-HCl-xtal-3D-balls.png
rdf:langString
HCl
xsd:integer
-2
rdf:langString
D07283
rdf:langString
D10627
rdf:langString
Rx-only
rdf:langString
POM
rdf:langString
Schedule III
rdf:langString
a619017
xsd:integer
1
xsd:integer
1
xsd:integer
182137
rdf:langString
CN[C@]1CCCCC1=O
xsd:integer
1
rdf:langString
YQEZLKZALYSWHR-ZDUSSCGKSA-N
rdf:langString
-Ketamine; S-Ketamine; JNJ-54135419
rdf:langString
background:#ccccff
rdf:langString
Spravato, Ketanest, others
xsd:integer
50
rdf:langString
L8P1H35P2Z
rdf:langString
verified
xsd:integer
461095357
rdf:langString
verified
xsd:integer
150
175
rdf:langString
إيسكيتامين (بالإنجليزية: Esketamine) دواء يستخدم كمخدر عام، ولمعالجة الاكتئاب المقاوم للعلاج، يستخدم الإيسكيتامين عن طريق الأنف أو عن طريق الوريد.
rdf:langString
Esketamine, also known as (S)-ketamine or S(+)-ketamine, is the S(+) enantiomer of ketamine, is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression. It is sold under the brand names Spravato (for depression), Ketanest (for anesthesia), among others. Esketamine is the active enantiomer of ketamine in terms of NMDA receptor antagonism and is more potent than racemic ketamine. It is specifically used as a therapy for treatment-resistant depression (TRD) and for major depressive disorder (MDD) with co-occurring suicidal ideation or behavior. Its effectiveness for depression is modest and similar to that of other antidepressants. Esketamine is used by infusion into a vein for anesthesia and under direct medical supervision as a nasal spray once or twice weekly for depression. Adverse effects of esketamine include dissociation, dizziness, sedation, nausea, vomiting, vertigo, numbness, anxiety, lethargy, increased blood pressure, and feelings of drunkenness. Less often, esketamine can cause bladder problems. Esketamine acts primarily as a N-methyl-D-aspartate (NMDA) receptor antagonist but also has other actions. In the form of racemic ketamine, esketamine was first synthesized in 1962 and introduced for medical use as an anesthetic in 1970. Enantiopure esketamine was introduced for medical use as an anesthetic in 1997 and as an antidepressant in 2019. It is used as an anesthetic in the European Union and as an antidepressant in the United States and Canada. Due to misuse liability as a dissociative hallucinogen, esketamine is a controlled substance.
rdf:langString
L'eskétamine, commercialisée en France sous les marques Eskesia et Spravato entre autres, est un médicament utilisé comme anesthésique général et pour la dépression réfractaire au traitement. L'eskétamine est utilisée en spray nasal ou par injection intraveineuse. L'eskétamine agit principalement comme antagoniste non compétitif du récepteur D- aspartate de N-méthyle (NMDA). Il agit également dans une certaine mesure en tant qu'inhibiteur de la recapture de la dopamine mais, contrairement à la kétamine, n'interagit pas avec les récepteurs sigma. Le composé est l'énantiomère S (+) de l'hydrochlorure de kétamine, qui est un anesthésique dissociatif et similaire. On ignore si son action antidépressive est supérieure, inférieure ou égale au racémique de kétamine et à son énantiomère R, l’arkétamine, tous deux étudiés pour le traitement de la dépression. L'eskétamine a été introduite pour un usage médical en 1997. En 2019, elle a été approuvée pour être utilisée avec d'autres antidépresseurs pour le traitement de la dépression chez les adultes aux États-Unis. Le coût du spray nasal à partir de 2019 sera de 4 700 USD à 6 800 USD pour le premier mois.
rdf:langString
Escetamina(pt-BR) ou esketamina(pt-PT?), vendida sob as marcas Ketanest, Spravato, entre outros, é um medicamento usado como anestésico geral e no tratamento de depressão resistente. Escetamina é usada via spray nasal ou por meio de injeção intravenosa. A escetamina atua principalmente como um antagonista não competitivo do receptor N-metil D-Aspartato (NMDA). Também atua como um inibidor da recaptação da dopamina, mas, ao contrário da cetamina, não interage com os receptores sigma. O composto é o enantiômero S(+) da composição racêmica da cetamina, que também é um anestésico e dissociativo. Ainda não se sabe se sua ação antidepressiva é superior, inferior ou igual à cetamina racêmica e seu enantiômero oposto, a arcetamina. Escetamina foi introduzida para uso médico em 1997. Em 2019, foi aprovada para uso conjunto com outros antidepressivos, no tratamento da depressão em adultos nos Estados Unidos. O custo médio do spray nasal em 2019 variou de US$ 4.700 a US$ 6.800, algo em torno de R$ 14.800 a R$ 21.200 em valores de 2020.
rdf:langString
Esketamin, som säljs under bland annat varumärkena Ketanest och Spravato, är ett läkemedel som används som allmänt anestesimedel och för depression. Esketamin används som nässpray eller intravenöst.
rdf:langString
Эскетамин — лекарственный препарат для наркоза и терапии депрессии. Одобрен для применения: США (2019).
rdf:langString
Esketamine
xsd:integer
9152
rdf:langString
S8
rdf:langString
Rx-only
rdf:langString
Rx-only
rdf:langString
yes
rdf:langString
Esketamine
rdf:langString
JC9
rdf:langString
B3
xsd:nonNegativeInteger
58937
rdf:langString
Spravato, Ketanest, others
xsd:string
33643-46-8
xsd:string
33643-47-9
xsd:string
60800
60799
xsd:string
2364609
395091
xsd:string
DB01221
xsd:string
DBSALT002086
xsd:string
50LFG02TXD
xsd:string
L8P1H35P2Z
xsd:string
D07283
D10627
xsd:string
a619017
xsd:string
182137
